AHPI, nan, nan,
AIH, 1 DAY AGO, Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China,
AIKI, FEB 3,2021,
AIM, 17 HOURS AGO, AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients in the Netherlands,
AKBA, 2 DAYS AGO, Akebia Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Discuss Recent Business Highlights,
AKER, DEC 2,2020,
AKRO, JAN 4,2021,
AKTX, FEB 1,2021,
AKU, NOV 2,2020,
AKUS, JAN 11,2021,
ALBO, JAN 25,2021,
ALC, JAN 20,2021,
ALDX, 6 DAYS AGO, Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design,
ALEC, JAN 25,2021,
ALGN, FEB 3,2021,
ALGS, FEB 3,2021,
ALIM, FEB 1,2021,
ALKS, 6 DAYS AGO, Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results,
ALLK, DEC 22,2020,
ALLO, 19 HOURS AGO, Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies,
ALNA, FEB 2,2021,
ALNY, JAN 28,2021,
ALPN, JAN 6,2021,
ALRN, JAN 11,2021,
ALT, DEC 30,2020,
ALVR, JAN 11,2021,
ALXN, 6 DAYS AGO, Alexion Reports Fourth Quarter and Full Year 2020 Results,
ALXO, JAN 11,2021,
AMED, 1 DAY AGO, Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date,
AMGN, 1 DAY AGO, Amgen To Present At Guggenheim Healthcare Talks Oncology Day,
AMPE, FEB 1,2021,
AMPH, DEC 29,2020,
AMRN, 1 DAY AGO, Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong,
AMRX, 6 DAYS AGO, Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26,
AMS, NOV 12,2020,
AMTI, JAN 19,2021,
AMYT, FEB 4,2021,
ANAB, JAN 7,2021,
ANCN, DEC 15,2020,
ANGN, 1 DAY AGO, Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement,
ANGO, FEB 1,2021,
ANIK, 1 DAY AGO, Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday,
ANIP, FEB 1,2021,
ANIX, JAN 13,2021,
ANNX, 2 DAYS AGO, Annexon Welcomes William H. Carson,
ANPC, 2 DAYS AGO, China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility),
ANTM, 2 DAYS AGO, Anthem to Host Virtual Investor Day Conference on March 3,
ANVS, 6 DAYS AGO, Annovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults,
APEN, 2 DAYS AGO, Apollo Endosurgery Announces CEO Transition,
APLS, 5 DAYS AGO, Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),
APLT, 10 HOURS AGO, Applied Therapeutics,
APM, JAN 20,2021,
APOP, NOV 20,2020,
APOPW, nan, nan,
APRE, JAN 8,2021,
APT, NOV 5,2020,
APTO, DEC 6,2020,
APTX, JAN 19,2021,
APVO, 1 DAY AGO, Aptevo Confirms Receipt of Nominations and Proposal Notice,
APYX, FEB 1,2021,
AQST, 1 DAY AGO, Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop,
ARAV, JAN 4,2021,
ARAY, 5 DAYS AGO, Accuray to Participate in BTIG's Virtual MedTech,
ARCT, JAN 6,2021,
ARDS, NOV 24,2020,
ARDX, NOV 23,2020,
ARGX, 5 DAYS AGO, argenx announces closing of global offering,
ARMP, JAN 27,2021,
ARNA, FEB 2,2021,
ARPO, JAN 5,2021,
ARQT, nan, nan,
ARTL, 2 DAYS AGO, Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants,
ARTLW, nan, nan,
ARVN, 2 DAYS AGO, Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day,
ARWR, 6 DAYS AGO, Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results,
ASLN, JAN 26,2021,
ASMB, 5 DAYS AGO, Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),
ASND, JAN 10,2021,
ASRT, 1 DAY AGO, Assertio Holdings,
ATEC, 2 DAYS AGO, ATEC to Report Fourth Quarter and Full Year 2020 Financial Results on March 4,
ATHA, 10 HOURS AGO, Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares,
ATHE, 1 DAY AGO, Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials,
ATHX, JAN 28,2021,
ATNF, JAN 11,2021,
ATNFW, nan, nan,
ATNM, 19 HOURS AGO, Actinium Announces Participation in BIO CEO & Investor Digital Conference,
ATNX, JAN 25,2021,
ATOS, 16 HOURS AGO, Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Accomplishments and Strategy for 2021,
ATRA, 2 DAYS AGO, Atara Biotherapeutics Presents Key Data for Advancing the Development of Tab-cel® and ATA188 at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience,
ATRC, 18 HOURS AGO, AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference,
ATRI, NOV 13,2020,
ATRS, JAN 11,2021,
ATXI, DEC 18,2020,
AUPH, JAN 22,2021,
AUTL, 1 DAY AGO, Autolus Announces Pricing of Public Offering,
AVDL, 18 HOURS AGO, Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference,
AVEO, JAN 20,2021,
AVGR, FEB 3,2021,
AVIR, 2 DAYS AGO, Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2,
AVNS, JAN 6,2021,
AVRO, 2 DAYS AGO, AVROBIO Announces 100% Kidney Substrate Reduction at 12 Months Post-Gene Therapy in First Patient Dosed with plato® Gene Therapy Platform in Fabry Disease Phase 2 Trial,
AVXL, 2 DAYS AGO, Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday,
AWH, 8 HOURS AGO, Aspira Women’s Health,
AXGN, 6 DAYS AGO, Axogen,
AXLA, JAN 11,2021,
AXNX, JAN 25,2021,
AXSM, DEC 31,2020,
AYLA, JAN 28,2021,
AYTU, 17 HOURS AGO, Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18,
AZN, JAN 12,2021,
AZRX, 1 DAY AGO, AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections,
AZYO, JAN 28,2021,
BASI, 1 DAY AGO, Bioanalytical Systems,
BAX, 6 DAYS AGO, Baxter Reports Fourth-Quarter and Full-Year 2020 Results,
BBI, JAN 19,2021,
BBIO, 5 DAYS AGO, BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),
BCAB, DEC 18,2020,
BCDA, FEB 2,2021,
BCDAW, nan, nan,
BCEL, NOV 12,2020,
BCLI, 1 DAY AGO, BrainStorm Announces Feedback from FDA Type-C Meeting on Future NurOwn® Manufacturing Plan,
BCRX, 1 DAY AGO, BioCryst to Present Data at 2021 American Academy of Allergy,
BCYC, JAN 26,2021,
BDSI, JAN 15,2021,
BDSX, 1 DAY AGO, Biodesix Publishes Data on New COVID-19 Artificial Intelligence (AI)-Based Algorithm for Use in Clinical Decision Support Systems,
BDTX, JAN 20,2021,
BDX, 6 DAYS AGO, BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance,
BDXB, DEC 2,2020,
BEAM, nan, nan,
BEAT, FEB 2,2021,
BFRA, FEB 2,2021,
BGNE, JAN 27,2021,
BHC, 1 DAY AGO, Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution),
BHVN, 2 DAYS AGO, Biohaven Provides Update On ESG Practices,
BIIB, 12 HOURS AGO, Biogen Announces the Pricing Terms of its Cash Tender Offer,
BIOC, FEB 3,2021,
BIOL, 10 HOURS AGO, BIOLASE,
BIVI, OCT 30,2020,
BKD, JAN 11,2021,
BLCM, 2 DAYS AGO, Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin,
BLFS, JAN 5,2021,
BLPH, JAN 4,2021,
BLRX, JAN 22,2021,
BLU, JAN 14,2021,
BLUE, JAN 11,2021,
BMRA, JAN 15,2021,
BMRN, JAN 28,2021,
BMY, 2 DAYS AGO, Adjuvant Treatment with Opdivo (nivolumab) Demonstrates Statistically Significant and Clinically Meaningful Improvement in Disease-Free Survival in Patients with Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial,
BNR, 2 DAYS AGO, Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11,
BNTC, DEC 7,2020,
BNTX, 22 HOURS AGO, Update on vaccine production at BioNTech’s manufacturing site in Marburg,
BOLT, 1 DAY AGO, Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,
BPMC, 17 HOURS AGO, Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday,
BPTH, 18 HOURS AGO, Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology,
BSGM, 15 HOURS AGO, Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems,
BSX, FEB 3,2021,
BTAI, 6 DAYS AGO, BioXcel Therapeutics to Present an Update from its Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium,
BVXV, 10 HOURS AGO, BiondVax Announces Exercise in Full of Underwriter's Over-Allotment Option in Follow-on Offering,
BWAY, JAN 25,2021,
BXRX, 17 HOURS AGO, Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16,
BYSI, DEC 29,2020,
CABA, JAN 7,2021,
CAH, 5 DAYS AGO, Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021,
CALA, JAN 11,2021,
CALT, 6 DAYS AGO, First Patient Dosed in NefIgArd Open Label Extension Study,
CANF, JAN 4,2021,
CAPR, FEB 1,2021,
CARA, JAN 11,2021,
CASI, JAN 28,2021,
CATB, JAN 29,2021,
CBAY, 18 HOURS AGO, CymaBay Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference,
CBIO, FEB 3,2021,
CBLI, DEC 22,2020,
CBMG, 2 DAYS AGO, Cellular Biomedicine Group,
CBPO, JAN 25,2021,
CCCC, JAN 19,2021,
CCM, DEC 28,2020,
CCXI, JAN 6,2021,
CDAK, 1 DAY AGO, Codiak Announces Proposed Public Offering of Common Stock,
CDMO, FEB 3,2021,
CDMOP, FEB 3,2021,
CDNA, 19 HOURS AGO, CareDx to to Participate in Upcoming BTIG Virtual MedTech,
CDTX, JAN 25,2021,
CELC, FEB 1,2021,
CEMI, JAN 14,2021,
CERC, FEB 2,2021,
CERE, JAN 28,2021,
CEREW, nan, nan,
CERS, 6 DAYS AGO, Cerus Corporation to Participate in Upcoming Virtual Investor Conferences,
CFMS, JAN 21,2021,
CFRX, NOV 13,2020,
CGEM, JAN 12,2021,
CGEN, DEC 23,2020,
CGIX, JAN 28,2021,
CHE, FEB 3,2021,
CHEK, JAN 27,2021,
CHEKZ, nan, nan,
CHFS, FEB 3,2021,
CHMA, JAN 19,2021,
CHRS, FEB 2,2021,
CI, 4 HOURS AGO, Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health,
CJJD, FEB 2,2021,
CKPT, JAN 6,2021,
CLBS, JAN 25,2021,
CLDX, JAN 4,2021,
CLLS, 10 HOURS AGO, Cellectis: Monthly information on share capital and company voting rights,
CLNN, JAN 19,2021,
CLNNW, nan, nan,
CLOV, 1 DAY AGO, Clover Health Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Clover Health Investments,
CLOVW, nan, nan,
CLPT, 5 DAYS AGO, ClearPoint Neuro,
CLRB, 18 HOURS AGO, Cellectar to Present at BIO CEO & Investor Digital Conference,
CLRBZ, nan, nan,
CLSD, 2 DAYS AGO, Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting,
CLSN, JAN 28,2021,
CLVR, 17 HOURS AGO, Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations,
CLVRW, nan, nan,
CLVS, 6 DAYS AGO, Clovis Oncology to Highlight Data at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting,
CMD, JAN 12,2021,
CMPI, JAN 4,2021,
CMPS, 1 DAY AGO, COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists,
CMRX, JAN 25,2021,
CNC, 7 HOURS AGO, Centene Corporation Prices Offering of Senior Notes,
CNCE, FEB 1,2021,
CNMD, JAN 27,2021,
CNSP, JAN 13,2021,
CNST, JAN 7,2021,
CNTG, DEC 18,2020,
CO, JAN 5,2021,
COCP, JAN 21,2021,
CODX, JAN 28,2021,
COGT, DEC 4,2020,
COLL, 2 DAYS AGO, Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutical to Join S&P SmallCap 600,
COO, 6 DAYS AGO, CooperCompanies Announces Release Date for First Quarter 2021,
CORT, 2 DAYS AGO, Corcept Therapeutics Announces Fourth Quarter,
CPHI, NOV 13,2020,
CPIX, NOV 17,2020,
CPRX, JAN 6,2021,
CRBP, JAN 20,2021,
CRDF, JAN 26,2021,
CRHM, 1 DAY AGO, CRH Medical Corporation Announces Acquisition of Oak Tree Anesthesia Associates,
CRIS, 1 DAY AGO, Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies,
CRL, JAN 28,2021,
CRMD, JAN 21,2021,
CRNX, 6 DAYS AGO, Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study,
CRSP, 5 DAYS AGO, CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day,
CRTX, 10 HOURS AGO, Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion,
CRVS, 6 DAYS AGO, Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19,
CRY, JAN 28,2021,
CSBR, JAN 19,2021,
CSII, 2 DAYS AGO, First Patient in Europe Treated With Cardiovascular Systems,
CSTL, 2 DAYS AGO, Castle Biosciences to Present at Upcoming Investor Conferences,
CSU, JAN 28,2021,
CTIC, 2 HOURS AGO, CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),
CTLT, 9 HOURS AGO, Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029,
CTMX, 6 DAYS AGO, CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day,
CTSO, 6 DAYS AGO, National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery,
CTXR, 2 DAYS AGO, Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing,
CTXRW, nan, nan,
CUE, 2 DAYS AGO, Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer,
CUTR, FEB 2,2021,
CVAC, 5 DAYS AGO, CureVac to Host Conference Call on COVID-19 Partnership Update on February 5,
CVET, JAN 28,2021,
CVM, JAN 8,2021,
CVS, FEB 2,2021,
CWBR, 1 DAY AGO, CohBar to Present at the BIO CEO & Investor Digital Conference,
CYAD, FEB 2,2021,
CYCC, 19 HOURS AGO, Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference,
CYCCP, 19 HOURS AGO, Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference,
CYCN, JAN 25,2021,
CYH, FEB 3,2021,
CYRX, 2 DAYS AGO, Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock,
CYTK, FEB 2,2021,
DARE, 1 DAY AGO, Daré Bioscience to Present at the 2021 BIO CEO & Investor Digital Conference,
DBVT, JAN 29,2021,
DCPH, 1 DAY AGO, Deciphera Pharmaceuticals,
DCTH, JAN 11,2021,
DFFN, JAN 11,2021,
DFHT, DEC 18,2020,
DFHTU, nan, nan,
DFHTW, nan, nan,
DGX, 1 DAY AGO, Quest Diagnostics to Host Virtual Investor Day On March 11,
DMAC, JAN 11,2021,
DMTK, 10 HOURS AGO, DermTech Enters Into Agreement with Blue Cross Blue Shield of Texas,
DNLI, 5 DAYS AGO, Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™,
DRIO, JAN 27,2021,
DRIOW, nan, nan,
DRNA, JAN 5,2021,
DRRX, 6 DAYS AGO, DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock,
DTIL, 6 DAYS AGO, Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day,
DVA, 4 DAYS AGO, DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc (NYSE:DVA) Investors,
DVAX, 2 DAYS AGO, Dong Yu,
DXCM, FEB 2,2021,
DXR, 5 DAYS AGO, DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER,
DYAI, FEB 3,2021,
DYN, 2 DAYS AGO, Dyne Therapeutics Appoints Ashish Dugar,
DYNT, FEB 1,2021,
EAR, JAN 26,2021,
EARS, JAN 29,2021,
EBS, 6 DAYS AGO, Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18,
ECOR, 1 DAY AGO, electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery,
EDAP, JAN 20,2021,
EDIT, 2 DAYS AGO, Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer,
EDSA, FEB 2,2021,
EGRX, FEB 2,2021,
EHC, 2 DAYS AGO, Encompass Health Corp. and Ascension St. John announce plans to build a 40-bed rehabilitation hospital in Owasso,
EIGR, 2 DAYS AGO, Eiger Announces ILIAD Study Results of Peginterferon Lambda in COVID-19 Published in Lancet Respiratory Medicine 2021,
ELAN, JAN 27,2021,
ELAT, nan, nan,
ELDN, JAN 19,2021,
ELMD, 1 DAY AGO, Electromed,
ELOX, 1 DAY AGO, Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic Fibrosis,
ENDP, JAN 26,2021,
ENLV, 1 DAY AGO, Enlivex Increases Previously Announced Bought Deal Offering to Approximately $46.0 Million of Ordinary Shares,
ENOB, SEP 10,2020,
ENSG, FEB 3,2021,
ENTA, 2 DAYS AGO, Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31,
ENTX, 2 DAYS AGO, Entera Bio Initiates New Research Program For Oral GLP-2,
ENTXW, nan, nan,
ENZ, FEB 3,2021,
EOLS, DEC 16,2020,
EPIX, JAN 13,2021,
EPZM, NOV 11,2020,
EQ, 1 DAY AGO, Equillium Announces the Appointment of Katherine Xu to the Board of Directors,
ERYP, 10 HOURS AGO, ERYTECH tiendra une présentation à l’occasion du BIO CEO & Investor Conference 2021,
ESPR, 1 DAY AGO, Esperion to Report Fourth Quarter and Full Year 2020 Financial Results February 23,
ESTA, 1 DAY AGO, Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation,
ETNB, JAN 5,2021,
ETON, 2 DAYS AGO, Eton Pharmaceuticals Announces Sale of Neurology Portfolio,
ETTX, JAN 26,2021,
EVFM, 6 DAYS AGO, Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®,
EVLO, JAN 28,2021,
EVOK, JAN 20,2021,
EW, JAN 31,2021,
EXAS, FEB 1,2021,
EXEL, 10 HOURS AGO, Exelixis Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update,
EYE, 6 DAYS AGO, National Vision Appoints Jose Armario to Board of Directors,
EYEG, FEB 1,2021,
EYEN, JAN 28,2021,
EYES, SEP 22,2020,
EYESW, nan, nan,
FATE, JAN 8,2021,
FBIO, FEB 2,2021,
FBIOP, nan, nan,
FBRX, NOV 24,2020,
FDMT, DEC 15,2020,
FENC, NOV 16,2020,
FGEN, DEC 22,2020,
FHTX, nan, nan,
FIXX, 2 DAYS AGO, Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome,
FLGT, JAN 6,2021,
FLXN, FEB 1,2021,
FMS, SEP 16,2020,
FMTX, JAN 20,2021,
FOLD, 2 DAYS AGO, Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021,
FONR, NOV 12,2020,
FPRX, 5 DAYS AGO, Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day,
FREQ, 2 DAYS AGO, Frequency Therapeutics Appoints Kevin Franck,
FRLN, 2 DAYS AGO, Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™,
FSTX, JAN 20,2021,
FULC, JAN 22,2021,
FUSN, DEC 16,2020,
FVE, JAN 28,2021,
FWP, JAN 12,2021,
GALT, DEC 11,2020,
GBIO, JAN 11,2021,
GBS, DEC 28,2020,
GBT, 5 DAYS AGO, GBT Announces New Employment Inducement Grants,
GEN           , FEB 2,2021,
GENE, JAN 25,2021,
GERN, JAN 21,2021,
GH, 6 DAYS AGO, Guardant Health to Report Fourth Quarter and Full Year 2020 Financial Results on February 24,
GHSI, JAN 28,2021,
GILD, 8 HOURS AGO, Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma,
GKOS, 6 DAYS AGO, Glaukos Corporation to Release Fourth Quarter and Full Year 2020 Financial Results after Market Close on February 25,
GLMD, JAN 26,2021,
GLPG, 17 HOURS AGO, Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF,
GLSI, JAN 29,2021,
GLTO, 1 DAY AGO, Galecto to Present at Upcoming Investor Conferences,
GLYC, JAN 7,2021,
GMAB, 10 HOURS AGO, Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer,
GMDA, 1 DAY AGO, Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR,
GMED, JAN 28,2021,
GMTX, 19 HOURS AGO, Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103 in Dry Age-Related Macular Degeneration (AMD) in Patients with High-Risk Genetic Variants,
GNCA, 6 DAYS AGO, Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast,
GNFT, 10 HOURS AGO, GENFIT annonce son calendrier financier pour 2021,
GNMK, JAN 11,2021,
GNPX, 1 DAY AGO, Genprex,
GOSS, 6 DAYS AGO, Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program,
GOVX, 2 DAYS AGO, GeoVax Announces Pricing of $9.0 Million Bought Deal Offering,
GOVXW, nan, nan,
GRAY, FEB 1,2021,
GRCL, JAN 19,2021,
GRFS, JAN 28,2021,
GRNV, 1 DAY AGO, GreenVision Acquisition Corp. Announces Contribution to Trust Account to Extend Time Period to Complete a Business Combination,
GRNVR, nan, nan,
GRNVU, DEC 4,2019,
GRNVW, nan, nan,
GRTS, FEB 1,2021,
GRTX, NOV 20,2020,
GSK, FEB 3,2021,
GTH, 1 DAY AGO, Genetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China,
GTHX, 6 DAYS AGO, G1 Therapeutics to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day Virtual Conference,
GWPH, 1 DAY AGO, Lexaria Outlook is Promising After Jazz Acquisition of GW,
GXGX, JAN 8,2021,
GXGXU, JAN 8,2021,
GXGXW, nan, nan,
HAE, FEB 2,2021,
HALO, 10 HOURS AGO, Halozyme To Host Fourth Quarter And Full Year 2020 Financial Results Webcast And Conference Call,
HARP, JAN 13,2021,
HCA, FEB 2,2021,
HCM, FEB 3,2021,
HCSG, 20 HOURS AGO, Healthcare Services Group,
HEC, JAN 13,2021,
HECCU, JAN 13,2021,
HECCW, nan, nan,
HEPA, 19 HOURS AGO, Former Novo Nordisk Executive,
HGEN, 2 DAYS AGO, Humanigen Elects Dr. Dale Chappell to Board of Directors,
HIMS, 10 HOURS AGO, Hims & Hers Health,
HJLI, 1 DAY AGO, Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering,
HJLIW, nan, nan,
HLF, 1 DAY AGO, Herbalife Nutrition to Present at CAGNY 2021 Virtual Conference,
HNGR, JAN 28,2021,
HOLX, 10 HOURS AGO, Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences,
HOOK, DEC 11,2020,
HOTH, 13 HOURS AGO, Hoth Therapeutics Scientific Advisory Board Member,
HRC, 5 DAYS AGO, Hillrom's Fiscal First Quarter Financial Results Exceed Guidance,
HRMY, DEC 17,2020,
HROW, 1 DAY AGO, Melt Pharmaceuticals Completes Phase 1 Study for Sublingual,
HRTX, JAN 21,2021,
HSDT, FEB 2,2021,
HSIC, 19 HOURS AGO, Henry Schein Announces Two New Directors,
HSKA, JAN 26,2021,
HSTO, JAN 19,2021,
HTBX, 1 DAY AGO, Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial,
HUGE, JAN 27,2021,
HUM, 18 HOURS AGO, Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration,
HZNP, FEB 3,2021,
IART, JAN 20,2021,
IBIO, 1 DAY AGO, iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday,
ICAD, JAN 19,2021,
ICCC, JAN 7,2021,
ICLR, 2 DAYS AGO, ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support,
ICPT, JAN 27,2021,
ICUI, 6 DAYS AGO, ICU Medical,
IDRA, JAN 11,2021,
IDXG, 6 DAYS AGO, Interpace Biosciences Announces CFO Leadership Transition,
IDXX, FEB 2,2021,
IDYA, 2 DAYS AGO, IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer,
IGMS, 5 DAYS AGO, IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day,
IKT, nan, nan,
IMAB, 19 HOURS AGO, I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors,
IMAC, 6 DAYS AGO, IMAC Holdings Continues Florida Expansion with Acquisition of Tampa Clinic,
IMACW, nan, nan,
IMCR, 23 HOURS AGO, Citi Appointed as Depositary Bank for Immunocore Holdings plc’s ADR Programme,
IMGN, FEB 1,2021,
IMMP, JAN 27,2021,
IMNM, FEB 3,2021,
IMRA, JAN 20,2021,
IMRN, JAN 11,2021,
IMRNW, nan, nan,
IMTX, DEC 2,2020,
IMTXW, JUL 2,2020,
IMUX, JAN 5,2021,
IMV, JAN 4,2021,
IMVT, FEB 2,2021,
INBX, FEB 1,2021,
INCY, 1 DAY AGO, Incyte Reports 2020 Fourth Quarter and Year-End Financial Results,
INFI, 11 HOURS AGO, Infinity Pharmaceuticals Announces Conference Call for the ASCO Genitourinary Cancers Symposium to Discuss Clinical Data from MARIO-275 Phase 2 Study,
INFU, FEB 3,2021,
INGN, 17 HOURS AGO, Inogen Announces Participation in the 10th Annual SVB Leerink Global Healthcare Conference,
INM, 5 DAYS AGO, InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results,
INMB, JAN 21,2021,
INMD, 19 HOURS AGO, InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth,
INO, JAN 25,2021,
INSM, 5 DAYS AGO, Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),
INSP, JAN 20,2021,
INVA, FEB 3,2021,
INVO, JAN 27,2021,
INZY, 6 DAYS AGO, Inozyme Pharma Appoints Deborah Wenkert,
IONS, JAN 7,2021,
IOVA, JAN 19,2021,
IPA, 8 HOURS AGO, IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares,
IPHA, 2 DAYS AGO, Innate Pharma Advances Lacutamab Clinical Development Program,
IQV, 19 HOURS AGO, IQVIA Reports Fourth-Quarter and Full-Year 2020 Results Raises Full-Year 2021 Guidance,
IRIX, JAN 11,2021,
IRMD, 6 DAYS AGO, IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results,
IRTC, JAN 29,2021,
IRWD, 2 DAYS AGO, Ironwood Pharmaceuticals Announces CEO Transition,
ISEE, JAN 5,2021,
ISR, 1 DAY AGO, Isoray Announces Second Quarter Fiscal 2021 Financial Results,
ISRG, JAN 21,2021,
ITCI, JAN 21,2021,
ITMR, 11 HOURS AGO, Itamar Medical Announces Closing of Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs,
ITOS, JAN 5,2021,
ITRM, 8 HOURS AGO, Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares,
IVA, nan, nan,
IVC, 11 HOURS AGO, Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31,
JAGX, 1 DAY AGO, Noted Natural Products Industry Veteran Dr. Nigel Gericke Joins Scientific Strategy Team for Jaguar Health’s Recently Launched Mental Health Entheogen Therapeutics Initiative,
JAZZ, 1 DAY AGO, Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on February 23,
JNCE, JAN 13,2021,
JNJ, 1 DAY AGO, Johnson & Johnson Vision Celebrates 20 Years of Helping Cataract Patients with the See More Campaign and Global Patient Story Search,
JWS, NOV 12,2020,
KALA, JAN 20,2021,
KALV, 5 HOURS AGO, KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock,
KDMN, 11 HOURS AGO, Kadmon Announces Proposed $150 Million Convertible Senior Notes Offering with Capped Call Transactions,
KDNY, FEB 2,2021,
KIDS, JAN 22,2021,
KIN, 1 DAY AGO, Kindred Biosciences Announces Two New Appointments to Board of Directors,
KLDO, FEB 3,2021,
KMDA, 19 HOURS AGO, Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results,
KMPH, JAN 27,2021,
KNSA, JAN 11,2021,
KNTE, nan, nan,
KOD, FEB 2,2021,
KPTI, 6 DAYS AGO, Karyopharm to Report Fourth Quarter and Full Year 2020 Financial Results on February 11,
KRBP, JAN 26,2021,
KRMD, JAN 25,2021,
KRON, JAN 26,2021,
KROS, DEC 21,2020,
KRTX, 23 HOURS AGO, PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares,
KRYS, FEB 2,2021,
KTRA, JAN 13,2021,
KURA, JAN 7,2021,
KYMR, 6 DAYS AGO, Kymera Therapeutics to Present at Upcoming February Investor Conferences,
KZIA, JAN 6,2021,
KZR, 11 HOURS AGO, Kezar Life Sciences to Present at BIO CEO & Investor Digital Conference,
LABP, FEB 3,2021,
LAKE, JAN 5,2021,
LCI, 1 DAY AGO, Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin,
LCTX, 2 DAYS AGO, Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury,
LEGN, FEB 1,2021,
LEXX, 1 DAY AGO, Lexaria Outlook is Promising After Jazz Acquisition of GW,
LEXXW, nan, nan,
LFVN, FEB 2,2021,
LGND, FEB 3,2021,
LGVW, 1 DAY AGO, Longview Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Butterfly Network,
LH, 1 DAY AGO, Labcorp Announces Key Appointments to Oncology Leadership Team,
LHCG, JAN 11,2021,
LHDX, 1 DAY AGO, Lucira Health Announces Closing of its Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,
LIFE, 1 DAY AGO, aTyr Pharma to Present at BIO CEO & Investor Digital Conference,
LIVN, JAN 20,2021,
LIXT, JAN 19,2021,
LIXTW, nan, nan,
LJPC, JAN 12,2021,
LLY, 1 DAY AGO, Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19,
LMAT, JAN 27,2021,
LMNL, JAN 27,2021,
LMNX, 2 DAYS AGO, Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results,
LNSR, 2 DAYS AGO, LENSAR to Present at Two Upcoming Investor Conferences,
LNTH, 6 DAYS AGO, Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting,
LOGC, JAN 7,2021,
LPCN, JAN 28,2021,
LPTX, JAN 6,2021,
LQDA, DEC 14,2020,
LRMR, DEC 15,2020,
LTRN, JAN 20,2021,
LUMO, DEC 18,2020,
LUNA, JAN 11,2021,
LUNG, JAN 28,2021,
LXRX, JAN 14,2021,
LYRA, JAN 22,2021,
MACK, NOV 5,2020,
MASI, 18 HOURS AGO, Masimo to Present in BTIG MedTech and Digital Health Conference,
MBIO, FEB 2,2021,
MBOT, 6 DAYS AGO, Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology,
MBRX, 11 HOURS AGO, Moleculin Announces Full Exercise of Over-Allotment Option,
MCK, FEB 2,2021,
MCRB, JAN 19,2021,
MD, 5 DAYS AGO, Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday,
MDGL, NOV 5,2020,
MDGS, 1 DAY AGO, Medigus: Smart Repair Pro Expands its Presence on Amazon Marketplace with Agreement to Purchase Two New Brands,
MDGSW, nan, nan,
MDNA, DEC 30,2020,
MDT, 1 DAY AGO, New Study in Newborns Finds Nellcor™ Pulse Oximetry Technology Provides Faster Stable Oxygen Saturation Readings Than Masimo Pulse Oximeter,
MDVL, 1 DAY AGO, MedAvail’s SpotRx Pharmacy and Cigna Medical Group Partner to Help Improve Medication Access in Phoenix,
MDXG, 19 HOURS AGO, MiMedx to Participate at the BTIG Virtual MedTech,
MEDP, JAN 5,2021,
MEDS, 1 DAY AGO, MedCheks LLC,
MEIP, 6 DAYS AGO, MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights,
MESO, 8 HOURS AGO, Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease,
MGLN, 20 HOURS AGO, Magellan Rx Management Announces Pilot with Digital Health Company,
MGNX, 2 DAYS AGO, MacroGenics to Participate in Upcoming Investor Conferences,
MGTA, 2 DAYS AGO, Magenta Therapeutics to Present Additional Data from Phase 1 MGTA-145 Stem Cell Mobilization Program and Preclinical Updates on Targeting Conditioning Program at Transplantation and Cellular Therapy (TCT) 2021 Annual Meeting,
MGTX, JAN 26,2021,
MIRM, 9 HOURS AGO, Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),
MIST, NOV 23,2020,
MITO, 19 HOURS AGO, Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares,
MLND, JAN 5,2021,
MLSS, 1 DAY AGO, Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee,
MMM, 1 DAY AGO, 3M Announces Upcoming Investor Events,
MMSI, 13 HOURS AGO, Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference,
MNKD, JAN 4,2021,
MNOV, JAN 31,2021,
MNPR, 1 DAY AGO, Monopar Announces Issuance of Patent Covering Composition of Matter for MNPR-101 in Canada,
MOH, 11 HOURS AGO, Molina Healthcare Reports Fourth Quarter and Year-End 2020 Financial Results,
MOR, JAN 25,2021,
MORF, JAN 5,2021,
MOTS, JAN 27,2021,
MREO, 20 HOURS AGO, Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares,
MRK, 6 DAYS AGO, Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results,
MRKR, JAN 13,2021,
MRNA, 1 DAY AGO, Moderna Announces COVID-19 Vaccine Supply Agreements with the Government of Taiwan for 5 Million Doses and the Government of Colombia for 10 Million Doses,
MRNS, 19 HOURS AGO, Marinus Pharmaceuticals to Provide Business Update and Announce Fourth Quarter and Full Year 2020 Financial Results on March 9,
MRSN, JAN 22,2021,
MRTX, 20 HOURS AGO, MD Anderson And Mirati Therapeutics Announce KRAS Strategic Research And Development Collaboration In Solid Tumors,
MRUS, FEB 1,2021,
MRVI, 20 HOURS AGO, Maravai LifeSciences Expands Its Intellectual Property Portfolio,
MSA, 1 DAY AGO, MSA Schedules Fourth Quarter Earnings Webcast,
MTCR, JAN 19,2021,
MTEM, JAN 19,2021,
MTNB, FEB 1,2021,
MTP, JAN 26,2021,
MYGN, 2 DAYS AGO, GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels,
MYO, JAN 26,2021,
MYOV, JAN 29,2021,
NAOV, 19 HOURS AGO, NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device,
NARI, FEB 3,2021,
NATR, NOV 9,2020,
NAVB, 2 DAYS AGO, Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis,
NBIX, 6 DAYS AGO, Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results,
NBRV, FEB 1,2021,
NBSE, JAN 28,2021,
NBTX, JAN 28,2021,
NBY, 2 DAYS AGO, NovaBay CEO Issues Letter to Stockholders,
NCNA, JAN 15,2021,
NDRA, JAN 26,2021,
NDRAW, nan, nan,
NEO, 5 DAYS AGO, NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24,
NEOG, FEB 1,2021,
NEOS, 19 HOURS AGO, Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18,
NEPH, JAN 12,2021,
NEPT, 20 HOURS AGO, Neptune Acquires Controlling Interest in Sprout Foods,
NERV, JAN 19,2021,
NFH, 18 HOURS AGO, New Frontier Health Corporation Announces Receipt of Clarification to Preliminary Non-Binding “Going Private” Proposal,
NGM, 1 DAY AGO, NGM Bio Announces Upcoming Oral Presentation of Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Angiogenesis,
NHC, DEC 17,2020,
NK, JAN 28,2021,
NKTR, JAN 6,2021,
NKTX, NOV 12,2020,
NLSP, FEB 2,2021,
NLSPW, nan, nan,
NLTX, 5 DAYS AGO, Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days,
NMRD, 6 DAYS AGO, Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing,
NMTR, 19 HOURS AGO, 9 Meters Biopharma,
NNOX, 2 DAYS AGO, Nanox Announces Secondary Offering of Ordinary Shares,
NNVC, 2 DAYS AGO, NanoViricides’s Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies,
NOVN, FEB 1,2021,
NRBO, JAN 21,2021,
NRC, 1 DAY AGO, National Research Corporation Announces Fourth Quarter and Year-to-Date 2020 Results,
NRIX, JAN 7,2021,
NSPR, 1 DAY AGO, InspireMD Appoints Leading Interventional Cardiologist Chris Metzger,
NSTG, 1 DAY AGO, Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas,
NTEC, DEC 9,2020,
NTLA, JAN 7,2021,
NTN, FEB 3,2021,
NTRA, FEB 3,2021,
NTUS, JAN 8,2021,
NURO, JAN 28,2021,
NUS, 1 DAY AGO, Nu Skin's Epoch Collection Is First Beauty Brand With New Eco-Pac Packaging,
NUVA, 2 DAYS AGO, NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area,
NVAX, 6 DAYS AGO, Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization,
NVCN, 19 HOURS AGO, Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market,
NVCR, 2 DAYS AGO, Novocure Announces Addition to Its Board of Directors,
NVIV, OCT 26,2020,
NVO, 16 HOURS AGO, Trading in Novo Nordisk shares by board members,
NVRO, FEB 1,2021,
NVS, JAN 26,2021,
NVST, 11 HOURS AGO, Envista Reports Fourth Quarter 2020 Results,
NVTA, 19 HOURS AGO, Invitae to Present at the 10th Annual SVB Leerink Global Healthcare Conference,
NXTC, JAN 14,2021,
NYMX, NOV 16,2020,
OBLN, NOV 6,2020,
OBSV, 2 HOURS AGO, ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares,
OCDX, 1 DAY AGO, Ortho Clinical Diagnostics Amends Credit Agreement to Extend Maturity and Increase Borrowing Capacity Under its Revolving Credit Facility,
OCGN, 3 DAYS AGO, Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market,
OCUL, 6 DAYS AGO, Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),
OCUP, JAN 20,2021,
OCX, 1 DAY AGO, Oncocyte Announces Closing of $40 Million Public Offering of Common Stock,
ODT, DEC 11,2020,
OFIX, JAN 28,2021,
OGEN, FEB 2,2021,
OGI, FEB 2,2021,
OLMA, DEC 17,2020,
OM, JAN 12,2021,
OMER, JAN 26,2021,
OMI, JAN 21,2021,
ONCR, 1 DAY AGO, Oncorus Announces Proposed Public Offering of Common Stock,
ONCS, FEB 2,2021,
ONCT, JAN 28,2021,
ONCY, DEC 9,2020,
ONEM, nan, nan,
ONTX, 9 HOURS AGO, Onconova Therapeutics,
ONTXW, nan, nan,
ONVO, SEP 3,2020,
OPCH, 2 DAYS AGO, Option Care Health Announces Upsizing and Pricing of Secondary Offering of 15,
OPGN, 1 DAY AGO, OpGen,
OPK, FEB 3,2021,
OPNT, 2 DAYS AGO, Opiant Pharmaceuticals Announces First Patient Dosed in Confirmatory Pharmacokinetic Study Assessing OPNT003,
OPTN, JAN 25,2021,
ORGO, 1 DAY AGO, Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March,
ORGS, NOV 5,2020,
ORIC, FEB 3,2021,
ORMP, JAN 27,2021,
ORPH, 6 DAYS AGO, Orphazyme to showcase data on arimoclomol in Niemann-Pick disease Type C during the 2021 Annual WORLDSymposium™,
ORTX, 1 DAY AGO, Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH),
OSH, 3 HOURS AGO, Oak Street Health Announces the Upsize and Pricing of Secondary Offering,
OSMT, FEB 1,2021,
OSUR, JAN 29,2021,
OTIC, 6 DAYS AGO, Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update,
OTLK, 6 DAYS AGO, Outlook Therapeutics’ Recent Financing Secures Funding to Support ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Through Planned BLA Submission,
OTLKW, nan, nan,
OTRK, 5 DAYS AGO, Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock,
OTRKP, 5 DAYS AGO, Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock,
OVID, DEC 16,2020,
OXFD, 6 DAYS AGO, Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses,
OYST, DEC 29,2020,
PAHC, 2 DAYS AGO, Phibro Animal Health Corporation to Participate in the Barclays Virtual Global Healthcare Conference,
PANA, 11 HOURS AGO, Nuvation Bio Closes Transaction with Panacea,
PAND, JAN 4,2021,
PASG, 2 DAYS AGO, FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease,
PAVM, 1 DAY AGO, PAVmed to Hold Business Update Conference Call on February 22,
PAVMW, nan, nan,
PAVMZ, nan, nan,
PBH, 9 HOURS AGO, Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes,
PBLA, 17 HOURS AGO, Panbela Announces Research Agreement with Johns Hopkins University School of Medicine,
PBYI, 1 DAY AGO, Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),
PCRX, 20 HOURS AGO, Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021,
PCSA, JAN 11,2021,
PCVX, JAN 6,2021,
PDCO, JAN 4,2021,
PDEX, 6 DAYS AGO, Pro-Dex,
PDSB, FEB 3,2021,
PEN, 11 HOURS AGO, Penumbra,
PETQ, NOV 10,2020,
PETS, JAN 19,2021,
PFE, 5 DAYS AGO, Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027,
PGEN, 6 DAYS AGO, Precigen to Participate in Guggenheim Healthcare Talks Oncology Day,
PGNY, 15 HOURS AGO, Progyny,
PHAR, nan, nan,
PHAS, JAN 28,2021,
PHAT, JAN 19,2021,
PHG, 1 DAY AGO, Philips completes the acquisition of BioTelemetry,
PHGE, FEB 2,2021,
PHIO, JAN 25,2021,
PHIOW, nan, nan,
PHVS, 1 DAY AGO, Pharvaris Announces Closing of Initial Public Offering,
PIRS, JAN 19,2021,
PLRX, JAN 12,2021,
PLSE, 6 DAYS AGO, Pulse Biosciences,
PLX, 20 HOURS AGO, Protalix BioTherapeutics and Chiesi Global Rare Diseases Present Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 17th Annual WORLDSymposium™ 2021,
PLXP, NOV 16,2020,
PMD, JAN 26,2021,
PMVP, NOV 24,2020,
PNTG, JAN 19,2021,
POAI, 3 HOURS AGO, Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules,
PODD, 2 DAYS AGO, Insulet to Present at Upcoming Investor Conferences,
PPBT, JAN 4,2021,
PPD, nan, nan,
PRAH, 6 DAYS AGO, PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings,
PRAX, JAN 7,2021,
PRFX, JAN 7,2021,
PRGO, JAN 11,2021,
PRLD, JAN 11,2021,
PROF, 1 DAY AGO, Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow,
PROG, 20 HOURS AGO, Progenity to Participate in Two Upcoming Investor Conferences,
PRPH, 1 DAY AGO, ProPhase Labs Begins Advanced,
PRQR, JAN 7,2021,
PRTA, 5 DAYS AGO, Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),
PRTC, 1 DAY AGO, PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares,
PRTK, 2 DAYS AGO, Paratek Announces Expansion of NUZYRA® Launch into the Community Setting,
PRVB, JAN 28,2021,
PSNL, 2 DAYS AGO, Personalis Expands Leadership Team with Appointment of Susan Moriconi,
PSTI, FEB 2,2021,
PSTV, JAN 5,2021,
PSTX, 19 HOURS AGO, Poseida Therapeutics to Host Virtual R&D Day on February 24,
PTCT, 6 DAYS AGO, PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy,
PTE, 19 HOURS AGO, PolarityTE Provides Corporate Update,
PTGX, JAN 29,2021,
PTN, 19 HOURS AGO, Palatin Technologies Announces Filing of International Patent Application Claiming PL9643,
PTPI, 6 DAYS AGO, Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil),
PULM, 3 HOURS AGO, Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules,
PYPD, 20 HOURS AGO, PolyPid Ltd. Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results,
QDEL, FEB 3,2021,
QGEN, 1 DAY AGO, QIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020,
QLGN, JAN 26,2021,
QLI, 2 DAYS AGO, Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021,
QTNT, FEB 1,2021,
QURE, 2 DAYS AGO, uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease,
RAD, 6 DAYS AGO, Rite Aid Opens More Than 300 New No-Charge COVID-19 Testing Sites,
RAPT, JAN 5,2021,
RARE, 6 DAYS AGO, Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2020 Financial Results and Corporate Update,
RCEL, FEB 3,2021,
RCKT, JAN 11,2021,
RCUS, 1 DAY AGO, Arcus Biosciences Announces New Employment Inducement Grants,
RDHL, 1 DAY AGO, RedHill Biopharma to Present at SVB Leerink Global Healthcare and BIO CEO & Investor Conferences,
RDNT, 14 HOURS AGO, RadNet Leases Significant New Space in Phoenix at Park Central,
RDUS, JAN 6,2021,
RDY, FEB 2,2021,
REGN, 1 DAY AGO, FDA Approves Libtayo® (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma,
REPH, DEC 18,2020,
REPL, 6 DAYS AGO, Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update,
RETA, DEC 4,2020,
RGEN, 2 DAYS AGO, Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines,
RGLS, 19 HOURS AGO, Regulus Therapeutics Announces Completion of Enrollment in First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD),
RGNX, 2 DAYS AGO, REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at 17th Annual WORLDSymposium™ 2021,
RIGL, JAN 29,2021,
RLAY, nan, nan,
RLMD, DEC 7,2020,
RMD, FEB 2,2021,
RMED, 6 DAYS AGO, Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors,
RMTI, 1 DAY AGO, Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis,
RNA, JAN 21,2021,
RNLX, nan, nan,
RPRX, JAN 22,2021,
RPTX, JAN 4,2021,
RUBY, 1 DAY AGO, Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results,
RVMD, 2 DAYS AGO, Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,
RVNC, JAN 25,2021,
RVP, JAN 8,2021,
RVPH, DEC 14,2020,
RVPHW, nan, nan,
RWLK, JAN 6,2021,
RYTM, 10 HOURS AGO, Rhythm Pharmaceuticals,
RZLT, 11 HOURS AGO, Rezolute Reports Second Quarter Fiscal 2021 Financial Results,
SAGE, 21 HOURS AGO, Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday,
SANA, 2 DAYS AGO, Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,
SAVA, 21 HOURS AGO, Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock,
SBBP, FEB 3,2021,
SBTX, nan, nan,
SCPH, DEC 7,2020,
SCPS, 7 HOURS AGO, Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full,
SCYX, DEC 22,2020,
SDC, 6 DAYS AGO, SmileDirectClub,
SDGR, nan, nan,
SEEL, FEB 1,2021,
SELB, JAN 6,2021,
SEM, JAN 21,2021,
SESN, FEB 1,2021,
SGEN, 11 HOURS AGO, Seagen and Genmab Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer,
SGMO, FEB 1,2021,
SGRY, JAN 28,2021,
SGTX, 2 DAYS AGO, Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™,
SHC, JAN 20,2021,
SIBN, 1 DAY AGO, SI-BONE To Report Fourth Quarter and Full Year 2020 Financial Results on March 8,
SIEN, 2 DAYS AGO, Sientra Announces Pricing of Public Offering of Common Stock,
SIGA, JAN 13,2021,
SILK, DEC 17,2020,
SINT, NOV 16,2020,
SIOX, 1 DAY AGO, Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31,
SLDB, JAN 6,2021,
SLGL, JAN 11,2021,
SLN, 5 DAYS AGO, Silence Therapeutics plc Announces $45 Million Private Placement,
SLNO, 5 DAYS AGO, Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome,
SLRX, JAN 21,2021,
SLS, JAN 14,2021,
SMMT, NOV 23,2020,
SMTI, JAN 25,2021,
SNCA, JAN 25,2021,
SNDX, DEC 18,2020,
SNGX, 1 DAY AGO, Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301,
SNGXW, nan, nan,
SNN, JAN 27,2021,
SNOA, JAN 28,2021,
SNSE, 10 HOURS AGO, Sensei Biotherapeutics Announces Closing of Initial Public Offering,
SNSS, DEC 7,2020,
SNY, 1 DAY AGO, FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma,
SOLY, 19 HOURS AGO, Soliton President & CEO Brad Hauser Named as Aesthetic Industry Association Advisory Board Member,
SONN, FEB 3,2021,
SPNE, 5 DAYS AGO, SeaSpine Reports Granting of Inducement Awards,
SPPI, 6 DAYS AGO, Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day,
SPRB, JAN 6,2021,
SPRO, 5 DAYS AGO, Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial,
SQZ, nan, nan,
SRDX, 1 DAY AGO, Surmodics Reports First Quarter Fiscal 2021 Results,
SRGA, JAN 27,2021,
SRNE, 1 DAY AGO, Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab,
SRPT, 6 DAYS AGO, Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition,
SRRA, 1 DAY AGO, Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),
SRRK, 6 DAYS AGO, Scholar Rock Announces Senior Management Promotions,
SRTS, JAN 6,2021,
SSKN, JAN 12,2021,
SSY, NOV 13,2020,
STAA, 20 HOURS AGO, STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24,
STE, FEB 3,2021,
STIM, 20 HOURS AGO, Neuronetics to Participate at the BTIG Virtual MedTech,
STOK, JAN 4,2021,
STRO, JAN 21,2021,
STRR, DEC 28,2020,
STRRP, DEC 28,2020,
STSA, NOV 24,2020,
STTK, JAN 7,2021,
STXS, 6 DAYS AGO, Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25,
SUPN, 2 DAYS AGO, Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients  ,
SURF, JAN 11,2021,
SVRA, DEC 10,2020,
SWAV, JAN 19,2021,
SWTX, 6 DAYS AGO, SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day,
SXTC, SEP 9,2020,
SYBX, 20 HOURS AGO, Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors,
SYK, FEB 2,2021,
SYN, DEC 22,2020,
SYNH, JAN 26,2021,
SYRS, JAN 19,2021,
TAK, 1 DAY AGO, Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease,
TARA, 6 DAYS AGO, Protara Therapeutics to Present at Upcoming Virtual Investor Conferences,
TARO, JAN 27,2021,
TARS, JAN 19,2021,
TBIO, FEB 3,2021,
TBPH, 21 HOURS AGO, Theravance Biopharma to Participate in Upcoming Investor Conferences,
TCDA, JAN 27,2021,
TCMD, 1 DAY AGO, Tactile Medical to Participate in Upcoming Investor Conferences in February and March,
TCON, JAN 19,2021,
TCRR, 6 DAYS AGO, TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors,
TDOC, 20 HOURS AGO, Teladoc Health to Announce Fourth-Quarter and Full-Year 2020 Financial Results,
TECH, 16 HOURS AGO, FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma,
TELA, 6 DAYS AGO, TELA Bio to Participate in Upcoming BTIG Virtual MedTech,
TENX, JAN 20,2021,
TERN, 20 HOURS AGO, Terns Pharmaceuticals,
TEVA, 19 HOURS AGO, Teva Reports Fourth Quarter and Full Year 2020 Financial Results,
TFFP, JAN 7,2021,
TFX, JAN 20,2021,
TGTX, 2 DAYS AGO, Rhizen Pharmaceuticals AG Announces That Its Partnered Asset,
THC, 19 HOURS AGO, Tenet Healthcare 15% Shareholder Glenview Capital Issues Letter of Support for Spin-Off of Conifer by Mid 2022,
THTX, 6 DAYS AGO, Theratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing Cancers,
TLC, 5 DAYS AGO, TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update,
TLGT, JAN 28,2021,
TLMD, JAN 26,2021,
TLMDW, nan, nan,
TLSA, 6 DAYS AGO," Tiziana Life Sciences plc (""Tiziana"" or the ""Company"") - Appointment of Director",
TMBR, JAN 25,2021,
TMDI, 1 DAY AGO, Titan Medical to Report Year-End 2020 Financial Results and Host Webcast on February 22,
TMDX, DEC 24,2020,
TNDM, JAN 19,2021,
TNXP, 19 HOURS AGO, Tonix Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference,
TPTX, 6 DAYS AGO, Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days,
TRIB, JAN 5,2021,
TRIL, DEC 7,2020,
TRUP, 11 HOURS AGO, Trupanion Reports Fourth Quarter and Full Year 2020 Results,
TRVI, FEB 1,2021,
TRVN, JAN 28,2021,
TRXC, 19 HOURS AGO, TransEnterix to Host Virtual Investor Day on February 23,
TSHA, 20 HOURS AGO, Taysha Gene Therapies Announces Participation in Upcoming Investor Healthcare Conferences,
TTNP, FEB 1,2021,
TTOO, 2 DAYS AGO, T2 Biosystems to Participate in the BTIG Virtual MedTech,
TVTX, 11 HOURS AGO, Travere Therapeutics Announces Proposed Public Offering of Common Stock,
TVTY, 1 DAY AGO, Tivity Health to Issue Fourth Quarter and Full Year 2020 Financial Results After Market Close on February 24,
TWST, 6 DAYS AGO, Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results,
TXMD, 11 HOURS AGO, TherapeuticsMD Announces Underwritten Public Offering of its Common Stock,
TYME, 2 DAYS AGO, TYME Announces Closing of $100 Million Registered Direct Offering of Common Stock,
UBX, 2 DAYS AGO, Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease,
UFPT, NOV 17,2020,
UHS, 2 DAYS AGO, Universal Health Services,
UNH, 6 DAYS AGO, UnitedHealth Group Announces Executive Leadership Actions,
URGN, JAN 13,2021,
UROV, DEC 23,2020,
USPH, JAN 21,2021,
UTHR, 21 HOURS AGO, United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®,
UTMD, 1 DAY AGO, Utah Medical Products,
VAPO, 11 HOURS AGO, Vapotherm to Report Fourth Quarter and Fiscal Year 2020 Financial Results,
VAR, 6 DAYS AGO, Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health,
VBIV, FEB 2,2021,
VBLT, JAN 27,2021,
VCEL, 19 HOURS AGO, Vericel to Report Fourth-Quarter 2020 Financial Results on February 24,
VCNX, JAN 5,2021,
VCYT, 19 HOURS AGO, Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17,
VERO, 1 DAY AGO, Venus Concept Inc. to Participate in the BTIG Virtual MedTech,
VERU, 20 HOURS AGO, Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter,
VIE, FEB 1,2021,
VINC, JAN 7,2021,
VINCU, JAN 7,2021,
VINCW, nan, nan,
VIR, FEB 1,2021,
VIRI, FEB 1,2021,
VIVE, 1 DAY AGO, Viveve Recognized for Leadership in Appointing Women to Board of Directors,
VIVO, 5 DAYS AGO, Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance,
VKTX, 11 HOURS AGO, Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17,
VKTXW, nan, nan,
VMD, JAN 7,2021,
VNDA, 11 HOURS AGO, Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results,
VNRX, 18 HOURS AGO, VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock,
VOR, 1 DAY AGO, PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering,
VRAY, JAN 26,2021,
VRCA, JAN 19,2021,
VRDN, JAN 19,2021,
VRNA, FEB 2,2021,
VRTX, FEB 1,2021,
VSTM, JAN 20,2021,
VTGN, JAN 6,2021,
VTRS, 1 DAY AGO, Viatris Inc. to Hold Conference Call on Monday,
VTVT, JAN 6,2021,
VVOS, FEB 2,2021,
VXRT, FEB 3,2021,
VYGR, FEB 2,2021,
VYNE, FEB 1,2021,
WBA, 18 HOURS AGO, Walgreens Boots Alliance Launches 2020 Corporate Social Responsibility Report,
WINT, 6 DAYS AGO, Windtree Strengthens Its Board by Appointing Three New Directors,
WVE, JAN 11,2021,
XAIR, 1 DAY AGO, Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update,
XBIO, JAN 14,2021,
XBIOW, nan, nan,
XBIT, JAN 21,2021,
XCUR, 1 DAY AGO, Exicure Announces Participation in 10th Annual SVB Leerink Global Healthcare Conference,
XENE, JAN 14,2021,
XENT, FEB 1,2021,
XERS, JAN 29,2021,
XFOR, FEB 2,2021,
XGN, FEB 3,2021,
XLRN, 6 DAYS AGO, Acceleron Announces Fourth Quarter and Full Year 2020 REBLOZYL® Net Sales,
XNCR, 6 DAYS AGO, Xencor to Present at Upcoming Investor Conferences,
XOMA, JAN 4,2021,
XOMAP, nan, nan,
XRAY, 6 DAYS AGO, Dentsply Sirona to Host Fourth Quarter and Full Year 2020 Conference Call on March 1st,
XTLB, nan, nan,
XTNT, DEC 7,2020,
YI, 5 DAYS AGO,111,
YMAB, JAN 6,2021,
YMTX, 20 HOURS AGO, Yumanity Therapeutics Provides Update on Its Lead Parkinson’s Disease Clinical Program,
ZBH, 21 HOURS AGO, Zimmer Biomet to Present at Citi's 2021 Healthcare Services,
ZEAL, 1 DAY AGO, Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference,
ZGNX, FEB 1,2021,
ZIOP, 5 DAYS AGO, Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors,
ZLAB, JAN 28,2021,
ZNTL, 21 HOURS AGO, Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors,
ZOM, 2 DAYS AGO, Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million,
ZSAN, FEB 1,2021,
ZTS, 10 HOURS AGO, Zoetis Declares Second Quarter 2021 Dividend,
ZYME, 11 HOURS AGO, Zymeworks to Participate in Upcoming Investor Conferences and Events,
ZYNE, JAN 4,2021,
ZYXI, JAN 28,2021,
